What they do
Unlearn.AI uses generative artificial intelligence to create TwinRCTs, which are randomized controlled trials utilizing digital twin cohorts. Pharmaceutical sponsors use these digital twins to reduce control group sizes, accelerate enrollment, and increase trial power.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- Clinical trial design
- Product type
- Platform software
- Stage
- Series C+
- Headquarters
- San Francisco, United States
- Region
- North America
- Founded
- 2017
- Total funding
- $130M raised
Notable investors: Altimeter Capital, Insight Partners, Radical Ventures, 8VC.